Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Defects, Congenital | 28 | 2019 | 1806 | 2.440 |
Why?
|
Genetic Diseases, Inborn | 10 | 2024 | 448 | 1.570 |
Why?
|
DNA Copy Number Variations | 13 | 2018 | 941 | 1.470 |
Why?
|
Genome, Human | 20 | 2022 | 1267 | 1.410 |
Why?
|
Rare Diseases | 7 | 2024 | 185 | 1.400 |
Why?
|
Homeodomain Proteins | 12 | 2020 | 543 | 1.380 |
Why?
|
Polymorphism, Single Nucleotide | 37 | 2022 | 2586 | 1.360 |
Why?
|
Mutation | 36 | 2020 | 5773 | 1.230 |
Why?
|
Genetic Predisposition to Disease | 22 | 2020 | 3084 | 1.150 |
Why?
|
Genetic Testing | 13 | 2024 | 995 | 1.150 |
Why?
|
Transcription Factors | 20 | 2020 | 2585 | 1.130 |
Why?
|
Heterotaxy Syndrome | 7 | 2019 | 62 | 1.100 |
Why?
|
Abnormalities, Multiple | 13 | 2011 | 964 | 1.030 |
Why?
|
Cardiovascular Abnormalities | 6 | 2014 | 51 | 1.010 |
Why?
|
Ventricular Outflow Obstruction | 6 | 2011 | 85 | 0.950 |
Why?
|
Body Patterning | 12 | 2019 | 122 | 0.950 |
Why?
|
Whole Genome Sequencing | 7 | 2024 | 286 | 0.920 |
Why?
|
Molecular Sequence Data | 54 | 2016 | 3868 | 0.920 |
Why?
|
Humans | 233 | 2024 | 123163 | 0.910 |
Why?
|
Genome-Wide Association Study | 11 | 2020 | 1641 | 0.890 |
Why?
|
Oligonucleotide Array Sequence Analysis | 15 | 2016 | 1012 | 0.890 |
Why?
|
Genomics | 12 | 2019 | 1478 | 0.880 |
Why?
|
X Chromosome | 16 | 2002 | 337 | 0.870 |
Why?
|
Hematopoietic Stem Cells | 19 | 2005 | 533 | 0.830 |
Why?
|
Cardiovascular Diseases | 5 | 2024 | 1863 | 0.810 |
Why?
|
Vascular Stiffness | 1 | 2023 | 75 | 0.790 |
Why?
|
Phenotype | 29 | 2024 | 4227 | 0.780 |
Why?
|
Genetics, Medical | 4 | 2016 | 117 | 0.770 |
Why?
|
Heart | 5 | 2017 | 723 | 0.740 |
Why?
|
Coloboma | 4 | 2005 | 45 | 0.730 |
Why?
|
Genetic Variation | 15 | 2016 | 1480 | 0.730 |
Why?
|
Base Sequence | 42 | 2015 | 3091 | 0.730 |
Why?
|
Male | 122 | 2024 | 60082 | 0.710 |
Why?
|
Aortic Aneurysm, Thoracic | 5 | 2011 | 662 | 0.710 |
Why?
|
Aortic Coarctation | 5 | 2013 | 105 | 0.710 |
Why?
|
Sequence Deletion | 10 | 2017 | 527 | 0.700 |
Why?
|
Zebrafish Proteins | 3 | 2019 | 105 | 0.700 |
Why?
|
Adenosine Deaminase | 15 | 1995 | 74 | 0.700 |
Why?
|
Gene Expression Profiling | 8 | 2019 | 1682 | 0.670 |
Why?
|
Female | 122 | 2024 | 65489 | 0.670 |
Why?
|
Sequence Analysis, DNA | 14 | 2019 | 1758 | 0.660 |
Why?
|
Exome | 11 | 2022 | 1041 | 0.660 |
Why?
|
Genotype | 23 | 2018 | 2541 | 0.640 |
Why?
|
Computational Biology | 6 | 2017 | 798 | 0.640 |
Why?
|
Chromosome Mapping | 18 | 2021 | 1081 | 0.640 |
Why?
|
Retroviridae | 17 | 1994 | 194 | 0.640 |
Why?
|
Hypoplastic Left Heart Syndrome | 5 | 2013 | 252 | 0.620 |
Why?
|
Infant | 41 | 2024 | 12347 | 0.610 |
Why?
|
Choanal Atresia | 4 | 2012 | 18 | 0.590 |
Why?
|
GTP Phosphohydrolases | 1 | 2019 | 142 | 0.590 |
Why?
|
Genetic Linkage | 9 | 2011 | 454 | 0.590 |
Why?
|
Polymerase Chain Reaction | 17 | 2005 | 1584 | 0.590 |
Why?
|
Genetic Vectors | 22 | 1995 | 940 | 0.570 |
Why?
|
Critical Illness | 1 | 2022 | 591 | 0.570 |
Why?
|
Pedigree | 25 | 2019 | 1584 | 0.560 |
Why?
|
Chromosome Deletion | 8 | 2018 | 638 | 0.560 |
Why?
|
Chromosome Disorders | 3 | 2019 | 309 | 0.550 |
Why?
|
Animals | 78 | 2019 | 33752 | 0.540 |
Why?
|
Amino Acid Sequence | 25 | 2016 | 2696 | 0.520 |
Why?
|
Aortic Valve Stenosis | 4 | 2009 | 329 | 0.500 |
Why?
|
Moyamoya Disease | 1 | 2015 | 39 | 0.490 |
Why?
|
Transforming Growth Factor beta | 8 | 2009 | 455 | 0.480 |
Why?
|
Repetitive Sequences, Nucleic Acid | 10 | 2011 | 368 | 0.480 |
Why?
|
Syndrome | 18 | 2018 | 1115 | 0.480 |
Why?
|
Deafness | 3 | 2005 | 81 | 0.470 |
Why?
|
Consanguinity | 2 | 2017 | 107 | 0.460 |
Why?
|
Child, Preschool | 43 | 2024 | 13886 | 0.460 |
Why?
|
Infant, Newborn | 32 | 2021 | 8106 | 0.450 |
Why?
|
Proteins | 7 | 2016 | 1037 | 0.450 |
Why?
|
Genetics, Population | 10 | 2011 | 189 | 0.440 |
Why?
|
Mice | 55 | 2016 | 17492 | 0.430 |
Why?
|
Aorta, Thoracic | 4 | 2023 | 519 | 0.430 |
Why?
|
Alleles | 15 | 2019 | 1603 | 0.430 |
Why?
|
Polymorphism, Genetic | 10 | 2009 | 809 | 0.430 |
Why?
|
Microfilament Proteins | 4 | 2012 | 276 | 0.420 |
Why?
|
Bronchiolitis, Viral | 1 | 2013 | 29 | 0.420 |
Why?
|
Haplotypes | 10 | 2012 | 519 | 0.420 |
Why?
|
Child | 49 | 2024 | 24234 | 0.420 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2015 | 353 | 0.410 |
Why?
|
Cohort Studies | 20 | 2020 | 4705 | 0.410 |
Why?
|
Chromosome Aberrations | 6 | 2019 | 614 | 0.410 |
Why?
|
Incidental Findings | 1 | 2013 | 125 | 0.410 |
Why?
|
Nucleoside Deaminases | 6 | 1990 | 26 | 0.400 |
Why?
|
Guidelines as Topic | 1 | 2013 | 197 | 0.400 |
Why?
|
Interferons | 1 | 2013 | 123 | 0.400 |
Why?
|
Genetic Techniques | 2 | 2011 | 107 | 0.390 |
Why?
|
Fenofibrate | 4 | 2013 | 58 | 0.390 |
Why?
|
Family | 6 | 2017 | 579 | 0.390 |
Why?
|
Precision Medicine | 3 | 2016 | 312 | 0.390 |
Why?
|
Transfection | 12 | 2016 | 1068 | 0.390 |
Why?
|
Aorta | 6 | 2023 | 541 | 0.380 |
Why?
|
Gene Expression Regulation, Developmental | 9 | 2012 | 996 | 0.380 |
Why?
|
Gene Dosage | 4 | 2013 | 441 | 0.380 |
Why?
|
Adolescent | 39 | 2024 | 19102 | 0.380 |
Why?
|
Genetic Diseases, X-Linked | 3 | 2012 | 65 | 0.370 |
Why?
|
Gene Frequency | 13 | 2011 | 713 | 0.370 |
Why?
|
Signal Transduction | 12 | 2016 | 4493 | 0.370 |
Why?
|
DNA Methylation | 5 | 2020 | 987 | 0.360 |
Why?
|
Lymphokines | 5 | 1991 | 66 | 0.360 |
Why?
|
Nuclear Proteins | 6 | 2016 | 1266 | 0.360 |
Why?
|
Genetic Markers | 15 | 2013 | 609 | 0.360 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2013 | 204 | 0.350 |
Why?
|
Cell Adhesion | 2 | 2010 | 318 | 0.340 |
Why?
|
Uniparental Disomy | 1 | 2010 | 49 | 0.340 |
Why?
|
DNA, Complementary | 6 | 2003 | 462 | 0.340 |
Why?
|
Craniofacial Abnormalities | 4 | 2009 | 244 | 0.340 |
Why?
|
Cardiomyopathies | 4 | 2024 | 478 | 0.340 |
Why?
|
Cell Line | 18 | 2004 | 2771 | 0.340 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2009 | 66 | 0.340 |
Why?
|
Hearing Loss | 1 | 2011 | 131 | 0.330 |
Why?
|
Membrane Proteins | 9 | 2017 | 1530 | 0.330 |
Why?
|
ErbB Receptors | 1 | 2011 | 284 | 0.330 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2013 | 334 | 0.330 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2010 | 239 | 0.330 |
Why?
|
Dyslipidemias | 4 | 2013 | 229 | 0.330 |
Why?
|
DNA Mutational Analysis | 10 | 2010 | 793 | 0.320 |
Why?
|
Aortic Rupture | 1 | 2010 | 118 | 0.320 |
Why?
|
Chromosomes, Human, Pair 2 | 4 | 2013 | 119 | 0.320 |
Why?
|
Protein-Tyrosine Kinases | 5 | 2012 | 211 | 0.320 |
Why?
|
Immunologic Deficiency Syndromes | 5 | 2016 | 201 | 0.320 |
Why?
|
Zebrafish | 7 | 2019 | 386 | 0.320 |
Why?
|
Genome | 3 | 2004 | 472 | 0.320 |
Why?
|
Cloning, Molecular | 7 | 1998 | 892 | 0.310 |
Why?
|
Developmental Disabilities | 7 | 2018 | 699 | 0.310 |
Why?
|
Ehlers-Danlos Syndrome | 3 | 2017 | 45 | 0.310 |
Why?
|
Linkage Disequilibrium | 4 | 2011 | 310 | 0.310 |
Why?
|
Young Adult | 21 | 2020 | 8862 | 0.300 |
Why?
|
Phosphoprotein Phosphatases | 2 | 2014 | 115 | 0.300 |
Why?
|
Recombinant Fusion Proteins | 6 | 2004 | 766 | 0.300 |
Why?
|
Adult | 35 | 2024 | 29057 | 0.300 |
Why?
|
Bone Marrow Cells | 9 | 2005 | 258 | 0.290 |
Why?
|
Genetic Association Studies | 4 | 2020 | 761 | 0.290 |
Why?
|
Dosage Compensation, Genetic | 5 | 1995 | 59 | 0.290 |
Why?
|
Chromosomes, Human, Pair 16 | 4 | 2012 | 150 | 0.290 |
Why?
|
Multifactorial Inheritance | 2 | 2005 | 137 | 0.290 |
Why?
|
Gene Products, tat | 3 | 1997 | 28 | 0.290 |
Why?
|
Gastrula | 2 | 2011 | 18 | 0.290 |
Why?
|
Forkhead Transcription Factors | 5 | 2016 | 368 | 0.290 |
Why?
|
DNA Helicases | 2 | 2005 | 224 | 0.290 |
Why?
|
Heart Ventricles | 6 | 2016 | 759 | 0.280 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2008 | 110 | 0.280 |
Why?
|
Genomic Imprinting | 3 | 2019 | 123 | 0.280 |
Why?
|
Bone and Bones | 2 | 2007 | 262 | 0.280 |
Why?
|
Nodal Protein | 6 | 2009 | 14 | 0.280 |
Why?
|
DNA-Binding Proteins | 7 | 2020 | 2047 | 0.280 |
Why?
|
Growth Inhibitors | 3 | 1991 | 37 | 0.280 |
Why?
|
Comparative Genomic Hybridization | 9 | 2016 | 574 | 0.280 |
Why?
|
Influenza, Human | 4 | 2015 | 649 | 0.280 |
Why?
|
Influenza A Virus, H1N1 Subtype | 3 | 2013 | 178 | 0.270 |
Why?
|
Chromosomes, Human, Pair 22 | 4 | 2012 | 102 | 0.270 |
Why?
|
RNA, Messenger | 9 | 2007 | 2814 | 0.270 |
Why?
|
Aortic Valve | 3 | 2005 | 432 | 0.270 |
Why?
|
Myocardium | 2 | 2012 | 984 | 0.270 |
Why?
|
Selection, Genetic | 5 | 2007 | 155 | 0.270 |
Why?
|
Mutation, Missense | 7 | 2016 | 847 | 0.270 |
Why?
|
Interleukin-6 | 5 | 1991 | 393 | 0.270 |
Why?
|
Agammaglobulinemia | 4 | 2012 | 39 | 0.260 |
Why?
|
Cluster Analysis | 7 | 2013 | 400 | 0.260 |
Why?
|
Facial Asymmetry | 1 | 2005 | 18 | 0.260 |
Why?
|
Conserved Sequence | 5 | 2015 | 293 | 0.260 |
Why?
|
Leukoencephalopathies | 2 | 2018 | 54 | 0.260 |
Why?
|
Gene Rearrangement | 3 | 2013 | 326 | 0.260 |
Why?
|
Fusion Proteins, bcr-abl | 4 | 2008 | 41 | 0.260 |
Why?
|
Case-Control Studies | 13 | 2019 | 3249 | 0.260 |
Why?
|
Germ-Line Mutation | 3 | 2017 | 313 | 0.250 |
Why?
|
Holoprosencephaly | 3 | 2011 | 23 | 0.250 |
Why?
|
Obesity | 4 | 2020 | 2227 | 0.250 |
Why?
|
Chromosomes, Human, Pair 14 | 3 | 2019 | 100 | 0.250 |
Why?
|
Cell Cycle Proteins | 2 | 2001 | 647 | 0.250 |
Why?
|
Intellectual Disability | 5 | 2018 | 1042 | 0.250 |
Why?
|
Genetic Counseling | 3 | 2017 | 225 | 0.250 |
Why?
|
Inheritance Patterns | 3 | 2017 | 125 | 0.250 |
Why?
|
Chromosomes, Human, Pair 17 | 2 | 2018 | 371 | 0.240 |
Why?
|
Wolff-Parkinson-White Syndrome | 2 | 2020 | 73 | 0.240 |
Why?
|
Cells, Cultured | 17 | 2016 | 3044 | 0.240 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2004 | 70 | 0.230 |
Why?
|
HeLa Cells | 5 | 2018 | 809 | 0.230 |
Why?
|
Nerve Tissue Proteins | 2 | 2008 | 1116 | 0.230 |
Why?
|
Semaphorins | 1 | 2004 | 31 | 0.230 |
Why?
|
Bone Marrow Transplantation | 9 | 1993 | 577 | 0.230 |
Why?
|
Hematopoiesis | 4 | 2008 | 216 | 0.230 |
Why?
|
Ear, Middle | 2 | 2016 | 26 | 0.230 |
Why?
|
High-Throughput Nucleotide Sequencing | 6 | 2022 | 863 | 0.230 |
Why?
|
Heterozygote | 6 | 2016 | 672 | 0.230 |
Why?
|
In Situ Hybridization, Fluorescence | 9 | 2010 | 757 | 0.220 |
Why?
|
Sequence Homology, Amino Acid | 8 | 2009 | 657 | 0.220 |
Why?
|
Stethoscopes | 1 | 2003 | 7 | 0.220 |
Why?
|
Oligodeoxyribonucleotides | 5 | 1996 | 135 | 0.220 |
Why?
|
Gene Expression | 6 | 2006 | 1566 | 0.220 |
Why?
|
Intercellular Signaling Peptides and Proteins | 5 | 2008 | 281 | 0.220 |
Why?
|
Models, Genetic | 7 | 2017 | 766 | 0.220 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2020 | 804 | 0.220 |
Why?
|
Genetic Heterogeneity | 3 | 2017 | 123 | 0.210 |
Why?
|
Mitochondrial Diseases | 3 | 2011 | 135 | 0.210 |
Why?
|
Failure to Thrive | 2 | 2008 | 90 | 0.210 |
Why?
|
Elasticity | 1 | 2023 | 92 | 0.210 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2018 | 151 | 0.210 |
Why?
|
Gene Deletion | 4 | 2008 | 794 | 0.210 |
Why?
|
Molecular Epidemiology | 1 | 2023 | 156 | 0.210 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2002 | 36 | 0.200 |
Why?
|
Thyroxine | 2 | 2012 | 65 | 0.200 |
Why?
|
Telemedicine | 2 | 2011 | 426 | 0.200 |
Why?
|
Apolipoproteins A | 2 | 2013 | 46 | 0.200 |
Why?
|
Nephrocalcinosis | 1 | 2002 | 7 | 0.200 |
Why?
|
Thymus Gland | 2 | 1994 | 99 | 0.200 |
Why?
|
Sucrase-Isomaltase Complex | 1 | 2002 | 19 | 0.200 |
Why?
|
Adenosine Triphosphatases | 3 | 2017 | 208 | 0.200 |
Why?
|
Sucrose | 1 | 2002 | 39 | 0.200 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 83 | 0.200 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 91 | 0.200 |
Why?
|
Persistent Fetal Circulation Syndrome | 2 | 2014 | 89 | 0.200 |
Why?
|
Promoter Regions, Genetic | 5 | 2013 | 1339 | 0.200 |
Why?
|
Carbohydrate Metabolism, Inborn Errors | 1 | 2002 | 36 | 0.200 |
Why?
|
Embryonic Development | 2 | 2019 | 209 | 0.200 |
Why?
|
Research Design | 2 | 2005 | 685 | 0.200 |
Why?
|
Immunity, Humoral | 2 | 2013 | 69 | 0.190 |
Why?
|
Cell Nucleolus | 1 | 2001 | 56 | 0.190 |
Why?
|
Embryo, Mammalian | 4 | 2012 | 452 | 0.190 |
Why?
|
Malformations of Cortical Development | 2 | 2018 | 53 | 0.190 |
Why?
|
Genes | 3 | 1993 | 444 | 0.190 |
Why?
|
Homozygote | 4 | 2017 | 533 | 0.190 |
Why?
|
Gene Duplication | 4 | 2012 | 358 | 0.180 |
Why?
|
Proto-Oncogene Proteins | 4 | 2009 | 550 | 0.180 |
Why?
|
Carrier Proteins | 3 | 2020 | 1019 | 0.180 |
Why?
|
Microbiota | 2 | 2016 | 388 | 0.180 |
Why?
|
HIV-1 | 2 | 1995 | 465 | 0.180 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2012 | 714 | 0.180 |
Why?
|
Adult Survivors of Child Adverse Events | 1 | 2020 | 15 | 0.180 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2008 | 98 | 0.180 |
Why?
|
Fetal Diseases | 3 | 2019 | 440 | 0.180 |
Why?
|
Oncogene Proteins | 3 | 2008 | 137 | 0.180 |
Why?
|
Gene Products, rev | 2 | 1997 | 11 | 0.180 |
Why?
|
Cancer Survivors | 2 | 2020 | 199 | 0.170 |
Why?
|
Cranial Irradiation | 1 | 2020 | 69 | 0.170 |
Why?
|
Gene Expression Regulation | 9 | 2016 | 2527 | 0.170 |
Why?
|
Triglycerides | 4 | 2016 | 562 | 0.170 |
Why?
|
Vascular Diseases | 2 | 2017 | 163 | 0.170 |
Why?
|
Eye Abnormalities | 2 | 2012 | 106 | 0.170 |
Why?
|
Sequence Alignment | 7 | 2011 | 623 | 0.170 |
Why?
|
Calcium | 2 | 2002 | 1096 | 0.170 |
Why?
|
Enhancer Elements, Genetic | 3 | 2006 | 297 | 0.170 |
Why?
|
Severe Acute Malnutrition | 1 | 2019 | 21 | 0.170 |
Why?
|
DNA | 15 | 2011 | 1592 | 0.170 |
Why?
|
Situs Inversus | 2 | 2016 | 25 | 0.170 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2002 | 667 | 0.160 |
Why?
|
Autopsy | 2 | 2016 | 110 | 0.160 |
Why?
|
Cardiology | 2 | 2024 | 472 | 0.160 |
Why?
|
Peroxidases | 1 | 2019 | 26 | 0.160 |
Why?
|
Pigmentation Disorders | 1 | 2018 | 23 | 0.160 |
Why?
|
Blotting, Southern | 5 | 2003 | 214 | 0.160 |
Why?
|
Body Mass Index | 3 | 2020 | 1541 | 0.160 |
Why?
|
Siblings | 4 | 2012 | 195 | 0.160 |
Why?
|
Genes, Lethal | 3 | 2014 | 76 | 0.160 |
Why?
|
Middle Aged | 13 | 2017 | 25992 | 0.160 |
Why?
|
Trisomy | 4 | 2010 | 103 | 0.160 |
Why?
|
Chromatids | 1 | 1998 | 43 | 0.160 |
Why?
|
Chromosomes, Human, Pair 1 | 3 | 2008 | 139 | 0.160 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2020 | 165 | 0.150 |
Why?
|
Acute Disease | 1 | 2021 | 1094 | 0.150 |
Why?
|
Megalencephaly | 1 | 2018 | 58 | 0.150 |
Why?
|
Evolution, Molecular | 3 | 2015 | 672 | 0.150 |
Why?
|
Genes, tat | 2 | 1995 | 10 | 0.150 |
Why?
|
Transduction, Genetic | 5 | 1992 | 290 | 0.150 |
Why?
|
N-Terminal Acetyltransferase A | 1 | 2018 | 8 | 0.150 |
Why?
|
N-Terminal Acetyltransferase E | 1 | 2018 | 8 | 0.150 |
Why?
|
Genetic Carrier Screening | 4 | 2015 | 75 | 0.150 |
Why?
|
Lung | 3 | 2016 | 1475 | 0.150 |
Why?
|
Muscular Dystrophy, Duchenne | 2 | 2011 | 63 | 0.150 |
Why?
|
Reproducibility of Results | 5 | 2017 | 2830 | 0.150 |
Why?
|
Extracellular Matrix Proteins | 2 | 2012 | 147 | 0.150 |
Why?
|
Brain | 5 | 2015 | 2961 | 0.150 |
Why?
|
Mosaicism | 3 | 2018 | 240 | 0.150 |
Why?
|
DiGeorge Syndrome | 3 | 2008 | 79 | 0.150 |
Why?
|
Xenopus | 2 | 2011 | 107 | 0.150 |
Why?
|
Congenital Abnormalities | 2 | 2014 | 249 | 0.150 |
Why?
|
Smad6 Protein | 1 | 2017 | 8 | 0.150 |
Why?
|
Cytoskeletal Proteins | 3 | 2020 | 269 | 0.150 |
Why?
|
Marfan Syndrome | 3 | 2012 | 137 | 0.150 |
Why?
|
Biomarkers | 5 | 2019 | 2946 | 0.150 |
Why?
|
Cell Adhesion Molecules | 2 | 2012 | 224 | 0.140 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2016 | 382 | 0.140 |
Why?
|
Registries | 2 | 2015 | 1392 | 0.140 |
Why?
|
CDC2 Protein Kinase | 1 | 2017 | 35 | 0.140 |
Why?
|
T-Lymphocytes | 4 | 1996 | 1676 | 0.140 |
Why?
|
Chromosomes, Human | 4 | 2011 | 131 | 0.140 |
Why?
|
Bone Marrow | 6 | 2004 | 323 | 0.140 |
Why?
|
Face | 2 | 2017 | 179 | 0.140 |
Why?
|
Sex Chromosome Aberrations | 2 | 1999 | 56 | 0.140 |
Why?
|
Moloney murine leukemia virus | 3 | 1991 | 19 | 0.140 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1997 | 287 | 0.140 |
Why?
|
Up-Regulation | 2 | 2013 | 864 | 0.140 |
Why?
|
Antigens, CD | 3 | 1994 | 421 | 0.140 |
Why?
|
Mobius Syndrome | 1 | 2017 | 8 | 0.140 |
Why?
|
Hemizygote | 1 | 2017 | 13 | 0.140 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 2 | 1994 | 16 | 0.140 |
Why?
|
Models, Biological | 4 | 2008 | 1441 | 0.140 |
Why?
|
Influenza Vaccines | 2 | 2013 | 473 | 0.140 |
Why?
|
Satiety Response | 1 | 2017 | 32 | 0.140 |
Why?
|
Mice, Inbred C57BL | 9 | 2014 | 4348 | 0.140 |
Why?
|
Phosphofructokinase-1 | 1 | 2016 | 5 | 0.140 |
Why?
|
Drinking | 1 | 2017 | 34 | 0.140 |
Why?
|
alpha-Macroglobulins | 1 | 2016 | 7 | 0.140 |
Why?
|
Quality Control | 2 | 2009 | 119 | 0.140 |
Why?
|
Genes, Duplicate | 1 | 2016 | 16 | 0.140 |
Why?
|
Acute-Phase Proteins | 2 | 2008 | 46 | 0.140 |
Why?
|
Population | 2 | 2009 | 21 | 0.140 |
Why?
|
Fibrillins | 3 | 2012 | 31 | 0.140 |
Why?
|
Tubulin | 1 | 2017 | 106 | 0.140 |
Why?
|
Influenza B virus | 2 | 2015 | 87 | 0.140 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1997 | 162 | 0.140 |
Why?
|
Fibrillin-1 | 3 | 2012 | 58 | 0.130 |
Why?
|
Membrane Glycoproteins | 3 | 2008 | 413 | 0.130 |
Why?
|
Noonan Syndrome | 2 | 2009 | 29 | 0.130 |
Why?
|
Soybean Oil | 1 | 2016 | 65 | 0.130 |
Why?
|
Death, Sudden | 1 | 2016 | 45 | 0.130 |
Why?
|
Mexican Americans | 3 | 2009 | 204 | 0.130 |
Why?
|
Otitis Media | 1 | 2016 | 82 | 0.130 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 428 | 0.130 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2016 | 32 | 0.130 |
Why?
|
DNA Replication | 2 | 2019 | 342 | 0.130 |
Why?
|
Lymphocytes | 2 | 1995 | 401 | 0.130 |
Why?
|
HIV | 1 | 1997 | 179 | 0.130 |
Why?
|
Fish Oils | 1 | 2016 | 82 | 0.130 |
Why?
|
Chromosomes, Human, X | 3 | 2012 | 157 | 0.130 |
Why?
|
Functional Laterality | 1 | 2016 | 181 | 0.130 |
Why?
|
Pulmonary Artery | 3 | 2009 | 439 | 0.130 |
Why?
|
Phospholipids | 1 | 2016 | 107 | 0.130 |
Why?
|
Apoptosis | 4 | 2008 | 1781 | 0.130 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2016 | 80 | 0.130 |
Why?
|
Spleen | 5 | 2008 | 272 | 0.130 |
Why?
|
DNA Primers | 6 | 2001 | 661 | 0.130 |
Why?
|
RNA, Untranslated | 1 | 1996 | 111 | 0.130 |
Why?
|
Informed Consent By Minors | 1 | 2015 | 4 | 0.130 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2016 | 63 | 0.130 |
Why?
|
Genes, rev | 1 | 1995 | 5 | 0.130 |
Why?
|
Aneuploidy | 2 | 2012 | 152 | 0.120 |
Why?
|
Atrophy | 1 | 2016 | 226 | 0.120 |
Why?
|
Genetics | 1 | 2015 | 25 | 0.120 |
Why?
|
Genetic Therapy | 6 | 1994 | 678 | 0.120 |
Why?
|
Biological Therapy | 1 | 2015 | 20 | 0.120 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2016 | 373 | 0.120 |
Why?
|
Echocardiography | 5 | 2011 | 1049 | 0.120 |
Why?
|
Muscle Hypotonia | 1 | 2016 | 185 | 0.120 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2011 | 359 | 0.120 |
Why?
|
Algorithms | 6 | 2017 | 1592 | 0.120 |
Why?
|
DNA, Bacterial | 1 | 2016 | 481 | 0.120 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2017 | 221 | 0.120 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2004 | 532 | 0.120 |
Why?
|
Abdominal Pain | 1 | 2017 | 306 | 0.120 |
Why?
|
Language Development Disorders | 2 | 2013 | 173 | 0.120 |
Why?
|
Transcriptome | 3 | 2016 | 905 | 0.120 |
Why?
|
Cholesterol, HDL | 2 | 2013 | 348 | 0.120 |
Why?
|
Scoliosis | 1 | 2016 | 134 | 0.120 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2014 | 22 | 0.120 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 1995 | 133 | 0.120 |
Why?
|
Gene Regulatory Networks | 2 | 2016 | 351 | 0.110 |
Why?
|
Exons | 7 | 2013 | 795 | 0.110 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1997 | 473 | 0.110 |
Why?
|
Urogenital Abnormalities | 1 | 2016 | 168 | 0.110 |
Why?
|
Hyperoxia | 1 | 2016 | 127 | 0.110 |
Why?
|
Texas | 6 | 2017 | 3555 | 0.110 |
Why?
|
Wheat Germ Agglutinins | 1 | 1993 | 14 | 0.110 |
Why?
|
Receptors, CXCR4 | 2 | 2004 | 58 | 0.110 |
Why?
|
Dilatation, Pathologic | 2 | 2011 | 93 | 0.110 |
Why?
|
Antigens, Ly | 1 | 1993 | 32 | 0.110 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2017 | 470 | 0.110 |
Why?
|
Databases, Factual | 1 | 2018 | 1168 | 0.110 |
Why?
|
DNA Breaks | 1 | 2013 | 26 | 0.110 |
Why?
|
Lipid Metabolism | 1 | 2016 | 352 | 0.110 |
Why?
|
Aging, Premature | 1 | 2013 | 31 | 0.110 |
Why?
|
Tetraspanins | 1 | 2013 | 30 | 0.110 |
Why?
|
Pulmonary Alveoli | 1 | 2014 | 134 | 0.110 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2016 | 184 | 0.110 |
Why?
|
Nasal Lavage Fluid | 1 | 2013 | 14 | 0.110 |
Why?
|
Practice Guidelines as Topic | 2 | 2017 | 1262 | 0.110 |
Why?
|
Autoimmunity | 1 | 2014 | 172 | 0.110 |
Why?
|
Health Status Disparities | 1 | 2015 | 219 | 0.110 |
Why?
|
Neuraminidase | 1 | 2013 | 34 | 0.100 |
Why?
|
Atrial Fibrillation | 1 | 2020 | 624 | 0.100 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2013 | 118 | 0.100 |
Why?
|
Angiopoietins | 1 | 2012 | 20 | 0.100 |
Why?
|
Gene Flow | 1 | 2012 | 13 | 0.100 |
Why?
|
Receptors, Cell Surface | 1 | 1995 | 468 | 0.100 |
Why?
|
Marriage | 1 | 2012 | 29 | 0.100 |
Why?
|
Apolipoproteins | 1 | 2012 | 68 | 0.100 |
Why?
|
Pneumonia | 1 | 2016 | 325 | 0.100 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2013 | 59 | 0.100 |
Why?
|
Microcephaly | 3 | 2009 | 328 | 0.100 |
Why?
|
Respiratory Tract Infections | 1 | 2015 | 263 | 0.100 |
Why?
|
Colon | 1 | 2015 | 353 | 0.100 |
Why?
|
Genetic Pleiotropy | 1 | 2012 | 24 | 0.100 |
Why?
|
Colitis, Ulcerative | 1 | 2015 | 207 | 0.100 |
Why?
|
Chromosomes, Human, Y | 1 | 2012 | 46 | 0.100 |
Why?
|
Antibodies, Viral | 3 | 2013 | 1135 | 0.100 |
Why?
|
Protein Interaction Maps | 1 | 2012 | 76 | 0.100 |
Why?
|
Pulmonary Veins | 1 | 2014 | 162 | 0.100 |
Why?
|
Apolipoproteins B | 1 | 2012 | 131 | 0.100 |
Why?
|
Alagille Syndrome | 3 | 2008 | 46 | 0.100 |
Why?
|
Chromosomes, Human, Pair 12 | 2 | 2005 | 93 | 0.100 |
Why?
|
Drosophila Proteins | 1 | 1997 | 707 | 0.100 |
Why?
|
Mice, Mutant Strains | 3 | 2006 | 381 | 0.100 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2009 | 22 | 0.100 |
Why?
|
Apolipoprotein C-III | 1 | 2012 | 36 | 0.100 |
Why?
|
Heart Diseases | 2 | 2009 | 482 | 0.100 |
Why?
|
CME-Carbodiimide | 1 | 1991 | 1 | 0.100 |
Why?
|
Constriction, Pathologic | 1 | 2012 | 237 | 0.100 |
Why?
|
Mice, SCID | 6 | 2008 | 571 | 0.100 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2012 | 92 | 0.100 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 3 | 1997 | 30 | 0.100 |
Why?
|
Feces | 1 | 2015 | 710 | 0.090 |
Why?
|
Protein Structure, Tertiary | 3 | 2009 | 752 | 0.090 |
Why?
|
GATA4 Transcription Factor | 1 | 2011 | 40 | 0.090 |
Why?
|
Indians, South American | 2 | 2008 | 14 | 0.090 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2011 | 78 | 0.090 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1991 | 5 | 0.090 |
Why?
|
Genes, erbB | 1 | 2011 | 2 | 0.090 |
Why?
|
Receptor, ErbB-4 | 1 | 2011 | 7 | 0.090 |
Why?
|
Aged, 80 and over | 4 | 2010 | 6371 | 0.090 |
Why?
|
Neuregulin-1 | 1 | 2011 | 13 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2016 | 554 | 0.090 |
Why?
|
Lipocalins | 2 | 2008 | 25 | 0.090 |
Why?
|
Isolated Noncompaction of the Ventricular Myocardium | 1 | 2011 | 43 | 0.090 |
Why?
|
Growth Disorders | 2 | 2011 | 207 | 0.090 |
Why?
|
Rhombencephalon | 1 | 2011 | 45 | 0.090 |
Why?
|
Ciliary Motility Disorders | 1 | 2010 | 12 | 0.090 |
Why?
|
Dyneins | 1 | 2010 | 13 | 0.090 |
Why?
|
Retroviridae Infections | 1 | 1990 | 10 | 0.090 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 849 | 0.090 |
Why?
|
Ear, Inner | 1 | 2011 | 52 | 0.090 |
Why?
|
Hair Cells, Auditory | 1 | 2011 | 64 | 0.090 |
Why?
|
Translocation, Genetic | 3 | 2004 | 352 | 0.090 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2011 | 159 | 0.090 |
Why?
|
Receptors, Androgen | 2 | 1995 | 409 | 0.090 |
Why?
|
Transcription, Genetic | 4 | 2015 | 1695 | 0.090 |
Why?
|
Family Practice | 1 | 2011 | 90 | 0.090 |
Why?
|
Chromosome Duplication | 1 | 2011 | 147 | 0.090 |
Why?
|
Down-Regulation | 1 | 2013 | 697 | 0.090 |
Why?
|
Ammonia | 1 | 1990 | 68 | 0.090 |
Why?
|
Craniosynostoses | 1 | 2012 | 131 | 0.090 |
Why?
|
Kanamycin Kinase | 2 | 2007 | 16 | 0.090 |
Why?
|
Delivery of Health Care | 1 | 2016 | 607 | 0.090 |
Why?
|
Academic Medical Centers | 2 | 2009 | 298 | 0.090 |
Why?
|
Nucleic Acid Hybridization | 2 | 2008 | 396 | 0.090 |
Why?
|
Amino Acid Substitution | 2 | 2018 | 389 | 0.090 |
Why?
|
Cilia | 1 | 2010 | 73 | 0.090 |
Why?
|
Calcium-Binding Proteins | 2 | 2008 | 327 | 0.090 |
Why?
|
Herpes Simplex | 1 | 1990 | 57 | 0.090 |
Why?
|
Muscle Contraction | 1 | 2010 | 186 | 0.090 |
Why?
|
DNA Repair | 1 | 2013 | 579 | 0.090 |
Why?
|
Bone Density | 1 | 2012 | 311 | 0.090 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2003 | 84 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2015 | 771 | 0.080 |
Why?
|
Aged | 8 | 2016 | 19080 | 0.080 |
Why?
|
Mice, Inbred BALB C | 5 | 1994 | 1002 | 0.080 |
Why?
|
Risk Factors | 7 | 2020 | 10008 | 0.080 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2012 | 280 | 0.080 |
Why?
|
Likelihood Functions | 1 | 2009 | 112 | 0.080 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2016 | 80 | 0.080 |
Why?
|
Hypolipidemic Agents | 1 | 2011 | 176 | 0.080 |
Why?
|
Protein Isoforms | 1 | 2011 | 408 | 0.080 |
Why?
|
Pediatrics | 1 | 2018 | 1138 | 0.080 |
Why?
|
Repressor Proteins | 2 | 2016 | 811 | 0.080 |
Why?
|
Andersen Syndrome | 1 | 2009 | 6 | 0.080 |
Why?
|
Plasmids | 3 | 2005 | 509 | 0.080 |
Why?
|
Postoperative Complications | 2 | 2020 | 3013 | 0.080 |
Why?
|
RNA, Viral | 1 | 1991 | 541 | 0.080 |
Why?
|
Microphthalmos | 1 | 2009 | 60 | 0.080 |
Why?
|
Cell Proliferation | 1 | 2016 | 2306 | 0.080 |
Why?
|
Chromosome Breakage | 2 | 2011 | 168 | 0.080 |
Why?
|
K562 Cells | 3 | 2008 | 95 | 0.080 |
Why?
|
Protein Binding | 3 | 2018 | 1740 | 0.080 |
Why?
|
Family Health | 2 | 2011 | 259 | 0.080 |
Why?
|
Amino Acids | 2 | 2013 | 658 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2013 | 5046 | 0.080 |
Why?
|
alpha-Galactosidase | 3 | 1999 | 20 | 0.080 |
Why?
|
Prevalence | 3 | 2015 | 2404 | 0.080 |
Why?
|
Zinc Fingers | 2 | 2011 | 113 | 0.080 |
Why?
|
Electric Countershock | 1 | 2009 | 67 | 0.080 |
Why?
|
Mucopolysaccharidosis II | 2 | 1998 | 18 | 0.080 |
Why?
|
Iduronate Sulfatase | 2 | 1998 | 20 | 0.080 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2008 | 84 | 0.080 |
Why?
|
Foreign-Body Migration | 1 | 2009 | 73 | 0.080 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2011 | 214 | 0.080 |
Why?
|
CpG Islands | 2 | 2019 | 321 | 0.080 |
Why?
|
Zinc Finger Protein Gli3 | 1 | 2008 | 7 | 0.080 |
Why?
|
Genetic Engineering | 2 | 1986 | 161 | 0.080 |
Why?
|
Receptor, Notch1 | 1 | 2008 | 66 | 0.070 |
Why?
|
GRB2 Adaptor Protein | 1 | 2007 | 6 | 0.070 |
Why?
|
Oligodeoxyribonucleotides, Antisense | 1 | 2007 | 7 | 0.070 |
Why?
|
Leukemia, Experimental | 1 | 2007 | 15 | 0.070 |
Why?
|
Vaccination | 1 | 2013 | 951 | 0.070 |
Why?
|
Databases, Genetic | 2 | 2016 | 470 | 0.070 |
Why?
|
Pilot Projects | 4 | 2017 | 1388 | 0.070 |
Why?
|
Tetralogy of Fallot | 2 | 2000 | 161 | 0.070 |
Why?
|
Heart Septal Defects, Ventricular | 3 | 2014 | 133 | 0.070 |
Why?
|
Prospective Studies | 5 | 2020 | 6032 | 0.070 |
Why?
|
Cell Cycle | 2 | 2001 | 614 | 0.070 |
Why?
|
Age of Onset | 4 | 2013 | 581 | 0.070 |
Why?
|
Colony-Forming Units Assay | 3 | 1991 | 69 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1991 | 477 | 0.070 |
Why?
|
RNA | 2 | 1992 | 572 | 0.070 |
Why?
|
Hyoid Bone | 1 | 2007 | 1 | 0.070 |
Why?
|
beta-Galactosidase | 2 | 1999 | 145 | 0.070 |
Why?
|
Spinal Curvatures | 1 | 2007 | 4 | 0.070 |
Why?
|
Phosphoglycerate Kinase | 1 | 2007 | 7 | 0.070 |
Why?
|
Leukemia Inhibitory Factor | 3 | 1991 | 26 | 0.070 |
Why?
|
Fingers | 1 | 2007 | 65 | 0.070 |
Why?
|
Cricoid Cartilage | 1 | 2007 | 16 | 0.070 |
Why?
|
In Situ Hybridization | 2 | 2011 | 473 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 6 | 2018 | 3543 | 0.070 |
Why?
|
Left-Right Determination Factors | 2 | 2004 | 3 | 0.070 |
Why?
|
Segmental Duplications, Genomic | 3 | 2012 | 81 | 0.070 |
Why?
|
Loss of Heterozygosity | 2 | 2006 | 124 | 0.070 |
Why?
|
Genes, Reporter | 1 | 2008 | 384 | 0.070 |
Why?
|
Recombinant Proteins | 5 | 1997 | 1386 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2011 | 420 | 0.070 |
Why?
|
Cytopathogenic Effect, Viral | 2 | 1997 | 29 | 0.070 |
Why?
|
Microsatellite Repeats | 2 | 2006 | 219 | 0.070 |
Why?
|
rev Gene Products, Human Immunodeficiency Virus | 2 | 1997 | 17 | 0.070 |
Why?
|
Disorders of Sex Development | 1 | 1987 | 78 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2011 | 1414 | 0.070 |
Why?
|
Defibrillators, Implantable | 1 | 2009 | 192 | 0.070 |
Why?
|
Animals, Newborn | 3 | 2016 | 991 | 0.070 |
Why?
|
Tissue Distribution | 2 | 2007 | 382 | 0.070 |
Why?
|
Endoderm | 1 | 2006 | 26 | 0.070 |
Why?
|
Gene Targeting | 1 | 2007 | 179 | 0.070 |
Why?
|
Triamcinolone Acetonide | 1 | 2006 | 36 | 0.070 |
Why?
|
Luciferases | 3 | 1995 | 137 | 0.070 |
Why?
|
Binding Sites | 2 | 2008 | 1291 | 0.060 |
Why?
|
Ocular Hypertension | 1 | 2006 | 26 | 0.060 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 2005 | 8 | 0.060 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2008 | 170 | 0.060 |
Why?
|
Embryonic Stem Cells | 1 | 2007 | 172 | 0.060 |
Why?
|
Mice, Knockout | 4 | 2014 | 3718 | 0.060 |
Why?
|
Cell Division | 5 | 2004 | 780 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2005 | 1009 | 0.060 |
Why?
|
RNA Splice Sites | 1 | 2005 | 87 | 0.060 |
Why?
|
Spinocerebellar Degenerations | 1 | 2005 | 63 | 0.060 |
Why?
|
Mice, Inbred C3H | 3 | 2005 | 118 | 0.060 |
Why?
|
Trinucleotide Repeats | 1 | 2005 | 109 | 0.060 |
Why?
|
Prenatal Diagnosis | 3 | 2006 | 588 | 0.060 |
Why?
|
Gastrointestinal Tract | 1 | 2007 | 208 | 0.060 |
Why?
|
Language | 1 | 2006 | 201 | 0.060 |
Why?
|
Pregnancy | 5 | 2019 | 7146 | 0.060 |
Why?
|
Molecular Probe Techniques | 1 | 2005 | 23 | 0.060 |
Why?
|
Mexico | 1 | 2005 | 179 | 0.060 |
Why?
|
Endoribonucleases | 1 | 2005 | 83 | 0.060 |
Why?
|
Hypergammaglobulinemia | 2 | 1996 | 11 | 0.060 |
Why?
|
Oleanolic Acid | 1 | 2004 | 6 | 0.060 |
Why?
|
Ligands | 3 | 2009 | 533 | 0.060 |
Why?
|
Maternal Age | 1 | 2005 | 136 | 0.060 |
Why?
|
Actins | 1 | 2007 | 340 | 0.060 |
Why?
|
Pneumonia, Viral | 1 | 1990 | 376 | 0.060 |
Why?
|
Time Factors | 5 | 2016 | 6217 | 0.060 |
Why?
|
Facies | 3 | 2011 | 155 | 0.060 |
Why?
|
Electron Transport Chain Complex Proteins | 1 | 2004 | 23 | 0.060 |
Why?
|
Ventricular Remodeling | 1 | 2005 | 174 | 0.060 |
Why?
|
Chromosome Inversion | 1 | 2005 | 76 | 0.060 |
Why?
|
Quantitative Trait, Heritable | 1 | 2005 | 109 | 0.060 |
Why?
|
Growth Differentiation Factor 1 | 3 | 2009 | 4 | 0.060 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2004 | 143 | 0.060 |
Why?
|
Cell Lineage | 2 | 2012 | 340 | 0.060 |
Why?
|
Cytochalasin B | 2 | 1981 | 9 | 0.060 |
Why?
|
Nutritional Status | 1 | 2006 | 304 | 0.060 |
Why?
|
Activin Receptors, Type II | 1 | 2004 | 30 | 0.060 |
Why?
|
Menkes Kinky Hair Syndrome | 1 | 2004 | 5 | 0.060 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2004 | 73 | 0.060 |
Why?
|
Cognition Disorders | 1 | 2008 | 555 | 0.060 |
Why?
|
Neuromuscular Diseases | 1 | 2004 | 55 | 0.060 |
Why?
|
Indians, Central American | 1 | 2003 | 3 | 0.060 |
Why?
|
Immunoglobulin M | 2 | 1996 | 210 | 0.060 |
Why?
|
Geography | 3 | 2009 | 112 | 0.060 |
Why?
|
Pandemics | 1 | 2011 | 1101 | 0.060 |
Why?
|
Caspases | 1 | 2004 | 158 | 0.060 |
Why?
|
Heart Murmurs | 1 | 2003 | 15 | 0.060 |
Why?
|
Alzheimer Disease | 1 | 2011 | 766 | 0.060 |
Why?
|
Myelin P0 Protein | 1 | 2003 | 25 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2006 | 280 | 0.060 |
Why?
|
Echocardiography, Doppler | 1 | 2004 | 170 | 0.060 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2016 | 512 | 0.050 |
Why?
|
West Nile Fever | 1 | 2005 | 139 | 0.050 |
Why?
|
Introns | 4 | 2016 | 302 | 0.050 |
Why?
|
Disease Management | 2 | 2017 | 514 | 0.050 |
Why?
|
Pharmacogenetics | 2 | 2015 | 183 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2006 | 378 | 0.050 |
Why?
|
Demyelinating Diseases | 1 | 2003 | 67 | 0.050 |
Why?
|
Hernia, Umbilical | 1 | 2003 | 41 | 0.050 |
Why?
|
Methylation | 2 | 1994 | 226 | 0.050 |
Why?
|
Cation Transport Proteins | 1 | 2004 | 97 | 0.050 |
Why?
|
Mice, Inbred NOD | 4 | 2005 | 285 | 0.050 |
Why?
|
Embryo, Nonmammalian | 3 | 2008 | 142 | 0.050 |
Why?
|
Quantitative Trait Loci | 2 | 2019 | 283 | 0.050 |
Why?
|
MAP Kinase Kinase 7 | 1 | 2002 | 11 | 0.050 |
Why?
|
Observer Variation | 1 | 2003 | 296 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 1994 | 57 | 0.050 |
Why?
|
Reference Standards | 1 | 2003 | 240 | 0.050 |
Why?
|
Apolipoprotein A-V | 2 | 2013 | 20 | 0.050 |
Why?
|
DNA Probes | 3 | 2005 | 123 | 0.050 |
Why?
|
Genes, Dominant | 2 | 2011 | 248 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2002 | 151 | 0.050 |
Why?
|
Length of Stay | 2 | 2018 | 1284 | 0.050 |
Why?
|
Apolipoprotein A-I | 2 | 2013 | 79 | 0.050 |
Why?
|
Crosses, Genetic | 1 | 2002 | 162 | 0.050 |
Why?
|
Risk | 1 | 2004 | 747 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2005 | 1683 | 0.050 |
Why?
|
Logistic Models | 3 | 2013 | 1793 | 0.050 |
Why?
|
Arthritis, Juvenile | 1 | 2002 | 39 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 111 | 0.050 |
Why?
|
History, 20th Century | 2 | 2015 | 383 | 0.050 |
Why?
|
Fabry Disease | 2 | 1999 | 17 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 130 | 0.050 |
Why?
|
Interphase | 1 | 2001 | 45 | 0.050 |
Why?
|
HL-60 Cells | 1 | 2001 | 31 | 0.050 |
Why?
|
Substrate Specificity | 1 | 2002 | 283 | 0.050 |
Why?
|
Multigene Family | 3 | 1998 | 298 | 0.050 |
Why?
|
Models, Economic | 1 | 2021 | 51 | 0.050 |
Why?
|
Jurkat Cells | 1 | 2001 | 76 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2020 | 16021 | 0.050 |
Why?
|
Elastin | 1 | 2001 | 32 | 0.050 |
Why?
|
Mitral Valve | 1 | 2003 | 246 | 0.050 |
Why?
|
Cell Line, Transformed | 1 | 2001 | 170 | 0.050 |
Why?
|
Ultraviolet Rays | 1 | 2002 | 204 | 0.050 |
Why?
|
Aortic Stenosis, Supravalvular | 1 | 2001 | 19 | 0.050 |
Why?
|
Sex Factors | 1 | 2005 | 1259 | 0.050 |
Why?
|
Thymidine Kinase | 2 | 1999 | 95 | 0.050 |
Why?
|
Graft Survival | 1 | 2004 | 525 | 0.050 |
Why?
|
Mental Disorders | 1 | 2008 | 821 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2002 | 206 | 0.050 |
Why?
|
Iduronidase | 1 | 2001 | 2 | 0.050 |
Why?
|
Mucopolysaccharidosis I | 1 | 2001 | 7 | 0.050 |
Why?
|
Hypertension | 1 | 2010 | 1287 | 0.050 |
Why?
|
Magnesium | 1 | 1981 | 121 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2013 | 350 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2002 | 617 | 0.050 |
Why?
|
Electrocardiography | 4 | 2011 | 958 | 0.050 |
Why?
|
Europe | 3 | 2006 | 374 | 0.050 |
Why?
|
Interleukin-3 | 3 | 2005 | 17 | 0.050 |
Why?
|
Mitosis | 1 | 2001 | 238 | 0.050 |
Why?
|
Neonatal Screening | 2 | 2012 | 184 | 0.050 |
Why?
|
Phosphorylation | 2 | 2001 | 1610 | 0.050 |
Why?
|
Rabbits | 1 | 2001 | 708 | 0.040 |
Why?
|
Neoplasm Transplantation | 3 | 2007 | 369 | 0.040 |
Why?
|
Central Nervous System | 1 | 2002 | 254 | 0.040 |
Why?
|
MAP Kinase Signaling System | 1 | 2002 | 315 | 0.040 |
Why?
|
Oncogenes | 1 | 2001 | 168 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2002 | 304 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 813 | 0.040 |
Why?
|
Behavior Therapy | 1 | 2002 | 256 | 0.040 |
Why?
|
LIM Domain Proteins | 1 | 2020 | 59 | 0.040 |
Why?
|
Nucleic Acid Conformation | 2 | 1991 | 184 | 0.040 |
Why?
|
Heart Valve Prosthesis | 1 | 2003 | 293 | 0.040 |
Why?
|
Fibroblasts | 3 | 2004 | 878 | 0.040 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 667 | 0.040 |
Why?
|
B-Lymphocytes | 2 | 2012 | 518 | 0.040 |
Why?
|
Hemorheology | 1 | 2000 | 28 | 0.040 |
Why?
|
Jamaica | 1 | 2019 | 25 | 0.040 |
Why?
|
Polymorphism, Single-Stranded Conformational | 2 | 1999 | 70 | 0.040 |
Why?
|
Leukopenia | 1 | 2000 | 44 | 0.040 |
Why?
|
Nonprescription Drugs | 1 | 2000 | 46 | 0.040 |
Why?
|
Mouth Mucosa | 1 | 2019 | 50 | 0.040 |
Why?
|
Gene Library | 2 | 1997 | 220 | 0.040 |
Why?
|
Neural Crest | 1 | 2000 | 51 | 0.040 |
Why?
|
Zinc | 1 | 2000 | 129 | 0.040 |
Why?
|
Glaucoma | 2 | 2006 | 89 | 0.040 |
Why?
|
Carbon-Nitrogen Ligases | 1 | 1999 | 2 | 0.040 |
Why?
|
India | 2 | 2012 | 217 | 0.040 |
Why?
|
Multiple Carboxylase Deficiency | 1 | 1999 | 3 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2002 | 451 | 0.040 |
Why?
|
Patient Compliance | 1 | 2002 | 467 | 0.040 |
Why?
|
Models, Molecular | 2 | 2016 | 1070 | 0.040 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2000 | 156 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2021 | 501 | 0.040 |
Why?
|
Mice, Inbred CBA | 1 | 1999 | 30 | 0.040 |
Why?
|
Adiposity | 1 | 2020 | 191 | 0.040 |
Why?
|
Ankyrins | 1 | 2020 | 99 | 0.040 |
Why?
|
Fetal Heart | 1 | 2000 | 111 | 0.040 |
Why?
|
Biotin | 1 | 1999 | 41 | 0.040 |
Why?
|
Parents | 2 | 2004 | 1030 | 0.040 |
Why?
|
Williams Syndrome | 1 | 1999 | 39 | 0.040 |
Why?
|
Morphogenesis | 1 | 2000 | 210 | 0.040 |
Why?
|
Epigenomics | 1 | 2019 | 162 | 0.040 |
Why?
|
Metaphase | 1 | 1998 | 44 | 0.040 |
Why?
|
Anaphase | 1 | 1998 | 20 | 0.040 |
Why?
|
DNA Topoisomerases, Type II | 1 | 1998 | 22 | 0.040 |
Why?
|
GATA2 Transcription Factor | 1 | 1999 | 45 | 0.040 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2003 | 427 | 0.040 |
Why?
|
Frameshift Mutation | 2 | 2013 | 175 | 0.040 |
Why?
|
Blood Vessels | 1 | 1999 | 104 | 0.040 |
Why?
|
Serrate-Jagged Proteins | 2 | 2008 | 38 | 0.040 |
Why?
|
Smad2 Protein | 2 | 2008 | 49 | 0.040 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 87 | 0.040 |
Why?
|
14-3-3 Proteins | 1 | 2018 | 54 | 0.040 |
Why?
|
Principal Component Analysis | 2 | 2009 | 142 | 0.040 |
Why?
|
Liver | 2 | 2016 | 1734 | 0.040 |
Why?
|
Centromere | 1 | 1998 | 107 | 0.040 |
Why?
|
Malawi | 1 | 2019 | 389 | 0.040 |
Why?
|
Neutropenia | 1 | 2000 | 202 | 0.040 |
Why?
|
Jagged-1 Protein | 2 | 2008 | 51 | 0.040 |
Why?
|
Enzyme Stability | 1 | 2018 | 58 | 0.040 |
Why?
|
Chromatin | 1 | 2001 | 552 | 0.040 |
Why?
|
Blotting, Northern | 1 | 1998 | 258 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2008 | 2390 | 0.040 |
Why?
|
Cytoplasm | 1 | 1979 | 289 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2012 | 1151 | 0.040 |
Why?
|
Histones | 1 | 2001 | 526 | 0.040 |
Why?
|
Flow Cytometry | 2 | 2004 | 803 | 0.040 |
Why?
|
Infant Care | 1 | 2017 | 46 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 2 | 2005 | 74 | 0.040 |
Why?
|
Kansas | 2 | 2011 | 6 | 0.040 |
Why?
|
Recombination, Genetic | 2 | 2007 | 442 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2012 | 1589 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2013 | 424 | 0.040 |
Why?
|
Heart Atria | 1 | 2020 | 312 | 0.040 |
Why?
|
Diabetes Complications | 1 | 2019 | 196 | 0.040 |
Why?
|
Biological Evolution | 1 | 1998 | 221 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2018 | 245 | 0.040 |
Why?
|
Chromosomes, Artificial, Yeast | 2 | 1995 | 41 | 0.040 |
Why?
|
GTP-Binding Protein beta Subunits | 1 | 2017 | 31 | 0.040 |
Why?
|
Collagen Type III | 1 | 2017 | 21 | 0.040 |
Why?
|
Chromosomes | 1 | 1998 | 198 | 0.040 |
Why?
|
Survivors | 1 | 2019 | 345 | 0.040 |
Why?
|
ATPases Associated with Diverse Cellular Activities | 1 | 2017 | 67 | 0.040 |
Why?
|
Muscle, Skeletal | 1 | 2003 | 937 | 0.030 |
Why?
|
Facial Paralysis | 1 | 2017 | 36 | 0.030 |
Why?
|
Lipocalin-2 | 2 | 2008 | 28 | 0.030 |
Why?
|
Eye Diseases, Hereditary | 1 | 2017 | 33 | 0.030 |
Why?
|
Philippines | 1 | 2016 | 23 | 0.030 |
Why?
|
Connective Tissue Diseases | 1 | 2017 | 29 | 0.030 |
Why?
|
Oryzias | 1 | 2016 | 9 | 0.030 |
Why?
|
Survival Analysis | 3 | 2006 | 1472 | 0.030 |
Why?
|
CD40 Ligand | 2 | 1996 | 64 | 0.030 |
Why?
|
Population Groups | 1 | 2016 | 29 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 30 | 0.030 |
Why?
|
PAX2 Transcription Factor | 1 | 2016 | 27 | 0.030 |
Why?
|
Datasets as Topic | 1 | 2017 | 85 | 0.030 |
Why?
|
Ocular Motility Disorders | 1 | 2017 | 38 | 0.030 |
Why?
|
Ophthalmoplegia | 1 | 2017 | 54 | 0.030 |
Why?
|
Metalloendopeptidases | 1 | 2017 | 101 | 0.030 |
Why?
|
Forecasting | 1 | 1998 | 354 | 0.030 |
Why?
|
Coroners and Medical Examiners | 1 | 2016 | 15 | 0.030 |
Why?
|
Consent Forms | 1 | 2016 | 23 | 0.030 |
Why?
|
Palmitic Acid | 1 | 2016 | 35 | 0.030 |
Why?
|
Sex Determination Analysis | 1 | 1996 | 16 | 0.030 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2016 | 34 | 0.030 |
Why?
|
Emulsions | 1 | 2016 | 65 | 0.030 |
Why?
|
Workflow | 1 | 2017 | 114 | 0.030 |
Why?
|
Y Chromosome | 1 | 1996 | 47 | 0.030 |
Why?
|
Genomic Library | 2 | 1999 | 39 | 0.030 |
Why?
|
Diagnosis | 1 | 2016 | 29 | 0.030 |
Why?
|
Mice, Inbred Strains | 2 | 1995 | 311 | 0.030 |
Why?
|
Cell Movement | 1 | 2000 | 831 | 0.030 |
Why?
|
Muscular Diseases | 1 | 2017 | 102 | 0.030 |
Why?
|
Regression Analysis | 2 | 2012 | 771 | 0.030 |
Why?
|
Amino Acid Motifs | 1 | 2016 | 199 | 0.030 |
Why?
|
Anemia | 1 | 2000 | 340 | 0.030 |
Why?
|
Orbital Diseases | 1 | 2017 | 92 | 0.030 |
Why?
|
Endoplasmic Reticulum-Associated Degradation | 1 | 2016 | 22 | 0.030 |
Why?
|
Dyspepsia | 1 | 2017 | 101 | 0.030 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2016 | 53 | 0.030 |
Why?
|
Cysteine | 1 | 2016 | 134 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 1997 | 326 | 0.030 |
Why?
|
Body Height | 1 | 2017 | 210 | 0.030 |
Why?
|
Restriction Mapping | 4 | 1999 | 188 | 0.030 |
Why?
|
Collagen | 1 | 2017 | 315 | 0.030 |
Why?
|
Transplantation, Heterologous | 2 | 2007 | 253 | 0.030 |
Why?
|
Fibrosarcoma | 1 | 1995 | 28 | 0.030 |
Why?
|
Confidentiality | 1 | 2016 | 101 | 0.030 |
Why?
|
Mitochondrial Proteins | 1 | 2017 | 239 | 0.030 |
Why?
|
Common Cold | 1 | 2015 | 24 | 0.030 |
Why?
|
Ethics, Medical | 2 | 2016 | 395 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2004 | 1661 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 1996 | 676 | 0.030 |
Why?
|
Chromosome Banding | 2 | 2011 | 139 | 0.030 |
Why?
|
Immunoglobulin Class Switching | 1 | 1995 | 13 | 0.030 |
Why?
|
Hospitalization | 2 | 2018 | 1726 | 0.030 |
Why?
|
Disclosure | 1 | 2016 | 154 | 0.030 |
Why?
|
Rhinovirus | 1 | 2015 | 59 | 0.030 |
Why?
|
RNA Splicing | 1 | 2016 | 223 | 0.030 |
Why?
|
Protein Folding | 1 | 2016 | 218 | 0.030 |
Why?
|
Age Factors | 2 | 2017 | 2802 | 0.030 |
Why?
|
Parenteral Nutrition | 1 | 2016 | 183 | 0.030 |
Why?
|
Hominidae | 1 | 1995 | 27 | 0.030 |
Why?
|
Chronic Pain | 1 | 2017 | 127 | 0.030 |
Why?
|
Hypertension, Pulmonary | 1 | 2000 | 430 | 0.030 |
Why?
|
Cerebellum | 2 | 2016 | 414 | 0.030 |
Why?
|
Caenorhabditis elegans | 1 | 2016 | 225 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2011 | 751 | 0.030 |
Why?
|
Double Outlet Right Ventricle | 1 | 2014 | 21 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2017 | 345 | 0.030 |
Why?
|
Reference Values | 2 | 2006 | 697 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2015 | 231 | 0.030 |
Why?
|
Densitometry | 1 | 2014 | 24 | 0.030 |
Why?
|
Influenza A virus | 1 | 2015 | 135 | 0.030 |
Why?
|
Clone Cells | 1 | 1994 | 163 | 0.030 |
Why?
|
RNA Interference | 1 | 2016 | 496 | 0.030 |
Why?
|
Zidovudine | 1 | 1994 | 22 | 0.030 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 33 | 0.030 |
Why?
|
Cinnamates | 1 | 1994 | 15 | 0.030 |
Why?
|
Virus Replication | 2 | 1995 | 603 | 0.030 |
Why?
|
History, 21st Century | 1 | 2015 | 272 | 0.030 |
Why?
|
Irritable Bowel Syndrome | 1 | 2017 | 205 | 0.030 |
Why?
|
Fatty Acids | 1 | 2016 | 338 | 0.030 |
Why?
|
CD40 Antigens | 1 | 1993 | 24 | 0.030 |
Why?
|
Aqueous Humor | 1 | 1993 | 27 | 0.030 |
Why?
|
RNA, Long Noncoding | 1 | 1996 | 207 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2014 | 198 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2014 | 3273 | 0.030 |
Why?
|
Immunoblotting | 1 | 2014 | 312 | 0.030 |
Why?
|
Gene Transfer Techniques | 1 | 1995 | 357 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 1994 | 182 | 0.030 |
Why?
|
Silicone Elastomers | 1 | 1993 | 35 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 2106 | 0.030 |
Why?
|
Radiation Protection | 1 | 1993 | 54 | 0.030 |
Why?
|
Receptors, Leukocyte-Adhesion | 1 | 1993 | 9 | 0.030 |
Why?
|
Epilepsy | 2 | 2012 | 858 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2015 | 659 | 0.030 |
Why?
|
Olivopontocerebellar Atrophies | 1 | 1993 | 2 | 0.030 |
Why?
|
Xenopus laevis | 1 | 2013 | 122 | 0.030 |
Why?
|
Deoxyribonuclease HpaII | 1 | 1992 | 8 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2014 | 184 | 0.030 |
Why?
|
Hybrid Cells | 1 | 1992 | 80 | 0.030 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1992 | 49 | 0.030 |
Why?
|
Granulocytes | 1 | 1993 | 65 | 0.030 |
Why?
|
Swine | 1 | 2016 | 1155 | 0.030 |
Why?
|
Angiopoietin-like Proteins | 1 | 2012 | 12 | 0.030 |
Why?
|
Hemagglutination Inhibition Tests | 1 | 2013 | 113 | 0.030 |
Why?
|
Antigens, CD19 | 1 | 1994 | 177 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 348 | 0.030 |
Why?
|
Body Weight | 1 | 2017 | 1001 | 0.030 |
Why?
|
Vitrectomy | 1 | 1993 | 107 | 0.030 |
Why?
|
Rosuvastatin Calcium | 1 | 2012 | 41 | 0.030 |
Why?
|
Stromal Cells | 1 | 1994 | 294 | 0.030 |
Why?
|
Rho Guanine Nucleotide Exchange Factors | 1 | 2012 | 18 | 0.030 |
Why?
|
Adenoviridae | 1 | 1995 | 608 | 0.030 |
Why?
|
Mesoderm | 1 | 2012 | 111 | 0.030 |
Why?
|
Blast Crisis | 1 | 1992 | 17 | 0.030 |
Why?
|
Leukemia, Myeloid, Chronic-Phase | 1 | 1992 | 11 | 0.030 |
Why?
|
Fluorobenzenes | 1 | 2012 | 38 | 0.030 |
Why?
|
Mothers | 1 | 2015 | 350 | 0.030 |
Why?
|
UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 1992 | 5 | 0.030 |
Why?
|
Cricetinae | 1 | 1992 | 408 | 0.030 |
Why?
|
United States | 2 | 2018 | 10631 | 0.030 |
Why?
|
Immunoglobulin A | 1 | 2013 | 197 | 0.020 |
Why?
|
Galactosemias | 1 | 1992 | 14 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 1993 | 150 | 0.020 |
Why?
|
Gestational Age | 2 | 2012 | 1136 | 0.020 |
Why?
|
Simvastatin | 1 | 2012 | 75 | 0.020 |
Why?
|
Genome, Mitochondrial | 1 | 2012 | 31 | 0.020 |
Why?
|
Heptanoic Acids | 1 | 2012 | 77 | 0.020 |
Why?
|
Critical Care | 1 | 2017 | 648 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2012 | 178 | 0.020 |
Why?
|
Lipoprotein Lipase | 1 | 2012 | 54 | 0.020 |
Why?
|
Copper | 2 | 2004 | 62 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 2025 | 0.020 |
Why?
|
Growth Substances | 1 | 1992 | 113 | 0.020 |
Why?
|
Carbodiimides | 1 | 1991 | 4 | 0.020 |
Why?
|
Butanones | 1 | 1991 | 7 | 0.020 |
Why?
|
Dystrophin | 1 | 2011 | 37 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2012 | 98 | 0.020 |
Why?
|
Sulfuric Acid Esters | 1 | 1991 | 9 | 0.020 |
Why?
|
Aldehydes | 1 | 1991 | 28 | 0.020 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1991 | 87 | 0.020 |
Why?
|
Genotyping Techniques | 1 | 2011 | 101 | 0.020 |
Why?
|
Monocytes | 1 | 1993 | 346 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 586 | 0.020 |
Why?
|
Cell Survival | 1 | 1993 | 806 | 0.020 |
Why?
|
Receptors, Odorant | 1 | 2011 | 36 | 0.020 |
Why?
|
N-Acetylgalactosaminyltransferases | 1 | 2011 | 7 | 0.020 |
Why?
|
Pulmonary Valve Stenosis | 1 | 2011 | 40 | 0.020 |
Why?
|
Models, Animal | 1 | 2013 | 464 | 0.020 |
Why?
|
Immunoglobulin mu-Chains | 1 | 1991 | 1 | 0.020 |
Why?
|
Myosin Heavy Chains | 1 | 2011 | 77 | 0.020 |
Why?
|
rho-Associated Kinases | 1 | 2011 | 55 | 0.020 |
Why?
|
Mutagens | 1 | 1991 | 84 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1991 | 29 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 251 | 0.020 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2011 | 10 | 0.020 |
Why?
|
Apolipoprotein E4 | 1 | 2011 | 43 | 0.020 |
Why?
|
Gene Order | 1 | 2011 | 78 | 0.020 |
Why?
|
Culture Media | 1 | 1991 | 182 | 0.020 |
Why?
|
Videoconferencing | 1 | 2011 | 21 | 0.020 |
Why?
|
Xenopus Proteins | 1 | 2011 | 60 | 0.020 |
Why?
|
Rural Health | 1 | 2011 | 47 | 0.020 |
Why?
|
Pyrroles | 1 | 2012 | 177 | 0.020 |
Why?
|
Helper Viruses | 1 | 1991 | 45 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 556 | 0.020 |
Why?
|
Vitreous Body | 2 | 2006 | 105 | 0.020 |
Why?
|
Genes, Viral | 1 | 1991 | 183 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2010 | 119 | 0.020 |
Why?
|
Simian virus 40 | 1 | 1991 | 197 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 1292 | 0.020 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 1981 | 39 | 0.020 |
Why?
|
Sulfonamides | 1 | 2012 | 259 | 0.020 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2011 | 107 | 0.020 |
Why?
|
Blood Cells | 1 | 1990 | 49 | 0.020 |
Why?
|
Oligonucleotides | 1 | 1990 | 88 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 1999 | 1877 | 0.020 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1991 | 132 | 0.020 |
Why?
|
Severe Combined Immunodeficiency | 1 | 1991 | 105 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2011 | 250 | 0.020 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2011 | 122 | 0.020 |
Why?
|
Contractile Proteins | 1 | 2010 | 17 | 0.020 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1990 | 46 | 0.020 |
Why?
|
Seasons | 1 | 2011 | 303 | 0.020 |
Why?
|
DNA, Viral | 1 | 1991 | 478 | 0.020 |
Why?
|
Filamins | 1 | 2010 | 25 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2011 | 12129 | 0.020 |
Why?
|
Genetic Loci | 1 | 2011 | 333 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2003 | 1907 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2013 | 770 | 0.020 |
Why?
|
Dogs | 1 | 2010 | 765 | 0.020 |
Why?
|
Radiography | 2 | 2009 | 823 | 0.020 |
Why?
|
Linear Models | 1 | 2011 | 669 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2013 | 1309 | 0.020 |
Why?
|
Pyrimidines | 1 | 2012 | 373 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2002 | 4275 | 0.020 |
Why?
|
Codon, Nonsense | 1 | 2010 | 131 | 0.020 |
Why?
|
Radiation Chimera | 1 | 1989 | 14 | 0.020 |
Why?
|
Recurrence | 2 | 2003 | 1422 | 0.020 |
Why?
|
Drug Resistance | 3 | 1995 | 256 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1991 | 1061 | 0.020 |
Why?
|
Phylogeny | 1 | 1991 | 689 | 0.020 |
Why?
|
Americas | 1 | 2009 | 50 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 1991 | 169 | 0.020 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2009 | 60 | 0.020 |
Why?
|
Child Behavior | 1 | 2011 | 232 | 0.020 |
Why?
|
Antibodies | 1 | 1990 | 369 | 0.020 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2011 | 306 | 0.020 |
Why?
|
Smad3 Protein | 1 | 2008 | 54 | 0.020 |
Why?
|
Basal Ganglia Diseases | 1 | 1988 | 27 | 0.020 |
Why?
|
Equipment Failure | 1 | 2009 | 122 | 0.020 |
Why?
|
Amidohydrolases | 1 | 1988 | 18 | 0.020 |
Why?
|
Skin Pigmentation | 1 | 2008 | 26 | 0.020 |
Why?
|
Computer Simulation | 1 | 1991 | 635 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2008 | 92 | 0.020 |
Why?
|
Argentina | 1 | 2008 | 52 | 0.020 |
Why?
|
Codon | 1 | 2008 | 96 | 0.020 |
Why?
|
In Vitro Techniques | 1 | 1990 | 966 | 0.020 |
Why?
|
Cytogenetic Analysis | 1 | 2008 | 79 | 0.020 |
Why?
|
Kinetics | 2 | 1981 | 1313 | 0.020 |
Why?
|
Aging | 1 | 1995 | 1174 | 0.020 |
Why?
|
Edar Receptor | 1 | 2007 | 9 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2008 | 93 | 0.020 |
Why?
|
Hirsutism | 1 | 2007 | 19 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2007 | 68 | 0.020 |
Why?
|
Antiporters | 1 | 2007 | 32 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2008 | 122 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2008 | 211 | 0.020 |
Why?
|
Mice, Inbred ICR | 1 | 2007 | 147 | 0.020 |
Why?
|
Motor Activity | 1 | 2011 | 522 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 1305 | 0.020 |
Why?
|
Indians, North American | 1 | 2007 | 58 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2007 | 247 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2011 | 477 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2007 | 239 | 0.020 |
Why?
|
Calcinosis | 1 | 1988 | 170 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2007 | 92 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 216 | 0.020 |
Why?
|
Liposomes | 1 | 2007 | 168 | 0.020 |
Why?
|
Middle East | 1 | 2006 | 34 | 0.020 |
Why?
|
Markov Chains | 1 | 2007 | 83 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2008 | 278 | 0.020 |
Why?
|
Deficiency Diseases | 1 | 2006 | 11 | 0.020 |
Why?
|
Defective Viruses | 1 | 1986 | 18 | 0.020 |
Why?
|
Lactase | 1 | 2006 | 41 | 0.020 |
Why?
|
Jews | 1 | 2006 | 32 | 0.020 |
Why?
|
New York | 1 | 2006 | 68 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 603 | 0.020 |
Why?
|
Phosphotransferases | 1 | 1986 | 41 | 0.020 |
Why?
|
Autistic Disorder | 1 | 2009 | 346 | 0.020 |
Why?
|
Purine-Pyrimidine Metabolism, Inborn Errors | 1 | 1986 | 3 | 0.020 |
Why?
|
Antiviral Agents | 1 | 1991 | 747 | 0.020 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 1986 | 35 | 0.020 |
Why?
|
Creatine Kinase, MM Form | 1 | 2005 | 6 | 0.020 |
Why?
|
Limb Deformities, Congenital | 1 | 1987 | 105 | 0.020 |
Why?
|
Utah | 1 | 2005 | 45 | 0.020 |
Why?
|
DNA Transposable Elements | 1 | 2006 | 177 | 0.020 |
Why?
|
Injections | 1 | 2006 | 153 | 0.020 |
Why?
|
Schizophrenia | 1 | 2008 | 300 | 0.020 |
Why?
|
Ataxins | 1 | 2005 | 114 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2005 | 42 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2006 | 316 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2011 | 640 | 0.020 |
Why?
|
Stem Cells | 1 | 1990 | 700 | 0.020 |
Why?
|
Diet, Protein-Restricted | 1 | 2006 | 82 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2011 | 694 | 0.020 |
Why?
|
Apoptosis Inducing Factor | 1 | 2004 | 1 | 0.020 |
Why?
|
Tetracycline | 1 | 2005 | 78 | 0.020 |
Why?
|
Fasting | 1 | 2006 | 297 | 0.020 |
Why?
|
Molecular Probes | 1 | 2005 | 30 | 0.020 |
Why?
|
Flavoproteins | 1 | 2004 | 17 | 0.020 |
Why?
|
Lentivirus | 1 | 2005 | 83 | 0.020 |
Why?
|
Electron Transport | 1 | 2004 | 54 | 0.010 |
Why?
|
Odds Ratio | 1 | 2008 | 1243 | 0.010 |
Why?
|
Phosphatidylserines | 1 | 2004 | 47 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2005 | 233 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 2838 | 0.010 |
Why?
|
Cell Death | 1 | 2005 | 243 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2006 | 729 | 0.010 |
Why?
|
PPAR gamma | 1 | 2004 | 91 | 0.010 |
Why?
|
Cataract | 1 | 1987 | 218 | 0.010 |
Why?
|
West Nile virus | 1 | 2005 | 117 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2006 | 229 | 0.010 |
Why?
|
Copper-transporting ATPases | 1 | 2004 | 25 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 171 | 0.010 |
Why?
|
Remission, Spontaneous | 1 | 2003 | 68 | 0.010 |
Why?
|
Acyltransferases | 1 | 2003 | 45 | 0.010 |
Why?
|
Mitochondrial Myopathies | 1 | 2003 | 28 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 2004 | 108 | 0.010 |
Why?
|
Sural Nerve | 1 | 2003 | 47 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 1990 | 1198 | 0.010 |
Why?
|
3T3 Cells | 2 | 1994 | 129 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2004 | 304 | 0.010 |
Why?
|
Systole | 1 | 2003 | 196 | 0.010 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2003 | 114 | 0.010 |
Why?
|
DNA, Mitochondrial | 1 | 2004 | 211 | 0.010 |
Why?
|
Karyotyping | 1 | 2003 | 330 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2006 | 254 | 0.010 |
Why?
|
Biological Transport | 1 | 2004 | 347 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2003 | 391 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2006 | 398 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2005 | 664 | 0.010 |
Why?
|
SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2002 | 2 | 0.010 |
Why?
|
src Homology Domains | 1 | 2002 | 29 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 1100 | 0.010 |
Why?
|
Ear | 1 | 2002 | 25 | 0.010 |
Why?
|
Protein Structure, Quaternary | 1 | 2002 | 98 | 0.010 |
Why?
|
Genitalia | 1 | 2002 | 36 | 0.010 |
Why?
|
Age Distribution | 1 | 2003 | 410 | 0.010 |
Why?
|
Catalytic Domain | 1 | 2002 | 159 | 0.010 |
Why?
|
Software | 1 | 2006 | 677 | 0.010 |
Why?
|
Isoenzymes | 1 | 2002 | 223 | 0.010 |
Why?
|
Leukemia | 1 | 2005 | 375 | 0.010 |
Why?
|
Stroke Volume | 1 | 2003 | 445 | 0.010 |
Why?
|
Suppressor Factors, Immunologic | 1 | 1981 | 4 | 0.010 |
Why?
|
Recovery of Function | 1 | 2003 | 437 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcr | 1 | 2001 | 10 | 0.010 |
Why?
|
Hepatomegaly | 1 | 2001 | 21 | 0.010 |
Why?
|
Corneal Opacity | 1 | 2001 | 23 | 0.010 |
Why?
|
Rats | 1 | 2007 | 3654 | 0.010 |
Why?
|
Tyrosine | 1 | 2001 | 152 | 0.010 |
Why?
|
Apnea | 1 | 2001 | 31 | 0.010 |
Why?
|
Splenomegaly | 1 | 2001 | 34 | 0.010 |
Why?
|
Range of Motion, Articular | 1 | 2001 | 73 | 0.010 |
Why?
|
Weight Gain | 1 | 2003 | 401 | 0.010 |
Why?
|
Growth | 1 | 2001 | 105 | 0.010 |
Why?
|
Serine | 1 | 2001 | 172 | 0.010 |
Why?
|
Acne Vulgaris | 1 | 2000 | 19 | 0.010 |
Why?
|
Self Medication | 1 | 2000 | 23 | 0.010 |
Why?
|
Exercise Tolerance | 1 | 2001 | 75 | 0.010 |
Why?
|
Blood Cell Count | 1 | 2000 | 69 | 0.010 |
Why?
|
Reoperation | 1 | 2003 | 819 | 0.010 |
Why?
|
Mitochondria | 1 | 2004 | 677 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2001 | 536 | 0.010 |
Why?
|
Glycerol Kinase | 1 | 1999 | 19 | 0.010 |
Why?
|
Mitomycins | 1 | 1979 | 10 | 0.010 |
Why?
|
Glycolipids | 1 | 1999 | 33 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2007 | 2056 | 0.010 |
Why?
|
Vinblastine | 1 | 1979 | 46 | 0.010 |
Why?
|
Colchicine | 1 | 1979 | 43 | 0.010 |
Why?
|
Gamma Rays | 1 | 1979 | 48 | 0.010 |
Why?
|
Hydrolases | 1 | 1999 | 52 | 0.010 |
Why?
|
Amniocentesis | 1 | 1999 | 76 | 0.010 |
Why?
|
Survival Rate | 1 | 2003 | 1996 | 0.010 |
Why?
|
Disease Progression | 1 | 2003 | 2026 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 1999 | 597 | 0.010 |
Why?
|
Deoxyadenine Nucleotides | 1 | 1995 | 6 | 0.010 |
Why?
|
Cats | 1 | 1995 | 116 | 0.010 |
Why?
|
Cosmids | 1 | 1995 | 48 | 0.010 |
Why?
|
Ganciclovir | 1 | 1995 | 102 | 0.010 |
Why?
|
Monosomy | 1 | 1995 | 24 | 0.010 |
Why?
|
Simplexvirus | 1 | 1995 | 105 | 0.010 |
Why?
|
Ephrin-B1 | 1 | 1995 | 8 | 0.010 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 1995 | 8 | 0.010 |
Why?
|
Polylysine | 1 | 1994 | 10 | 0.010 |
Why?
|
Capsules | 1 | 1994 | 21 | 0.010 |
Why?
|
Alginates | 1 | 1994 | 18 | 0.010 |
Why?
|
Membranes, Artificial | 1 | 1994 | 27 | 0.010 |
Why?
|
Protein Sorting Signals | 1 | 1994 | 37 | 0.010 |
Why?
|
Purines | 1 | 1995 | 107 | 0.010 |
Why?
|
Placenta | 1 | 1999 | 493 | 0.010 |
Why?
|
Nondisjunction, Genetic | 1 | 1994 | 19 | 0.010 |
Why?
|
Hygromycin B | 1 | 1994 | 2 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 1995 | 287 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 1994 | 123 | 0.010 |
Why?
|
Mutagenesis | 1 | 1995 | 347 | 0.010 |
Why?
|
Leukocytes | 1 | 1995 | 207 | 0.010 |
Why?
|
Olivary Nucleus | 1 | 1993 | 10 | 0.010 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 1993 | 91 | 0.010 |
Why?
|
CD18 Antigens | 1 | 1993 | 49 | 0.010 |
Why?
|
Crossing Over, Genetic | 1 | 1993 | 50 | 0.010 |
Why?
|
Pons | 1 | 1993 | 32 | 0.010 |
Why?
|
Myoclonus | 1 | 1993 | 32 | 0.010 |
Why?
|
Intraocular Pressure | 1 | 1993 | 144 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1993 | 104 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1993 | 262 | 0.010 |
Why?
|
Cell-Free System | 1 | 1992 | 106 | 0.010 |
Why?
|
Eye Diseases | 1 | 1993 | 113 | 0.010 |
Why?
|
Drainage | 1 | 1993 | 256 | 0.010 |
Why?
|
Gentamicins | 1 | 1992 | 95 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1991 | 85 | 0.010 |
Why?
|
Retinal Diseases | 1 | 1993 | 172 | 0.010 |
Why?
|
Homeostasis | 1 | 1995 | 682 | 0.010 |
Why?
|
Vaccines | 1 | 1995 | 369 | 0.010 |
Why?
|
Biotinidase | 1 | 1988 | 2 | 0.000 |
Why?
|
Visual Acuity | 1 | 1993 | 808 | 0.000 |
Why?
|
Species Specificity | 1 | 1988 | 549 | 0.000 |
Why?
|